Uterine fibroids are the most common benign tumors in women, with an incidence of about 20%-25% of women of reproductive age, and the prevalence of fibroids in women aged 40-50 is as high as 50%-61.2%. The common symptoms are increased menstrual flow, prolonged periods and even anemia, and some patients suffer from lower abdominal cramps and dysmenorrhea due to abdominal masses, which seriously affect their health. Although the former can achieve the purpose of radical cure, after the removal of the uterus, the patient will lose the reproductive function and other physiological functions, which has a great impact on the patient’s body and mind; the latter is prone to recurrence. In recent years, domestic and international literature has reported that premature ovarian failure occurs after hysterectomy even if the ovaries are preserved. Because the uterus is not only a reproductive organ, but also a target organ for endocrine regulation, hysterectomy can cause a series of symptoms such as increased blood glucose and lipids, endocrine disorders, increased menopausal symptoms, and decreased sexual function. Minimally invasive interventional therapy can overcome the adverse consequences of surgical resection, it can reduce the size of fibroids, improve and alleviate the symptoms, while preserving the uterus and its physiological functions, which is a new treatment worthy of attention and choice. This treatment is performed under the supervision of a large C-arm digital subtraction angiography machine, after the femoral artery is punctured and cannulated, the catheter is inserted into the bilateral internal iliac arteries for imaging, and after understanding the blood supply of the tumor, the catheter is super-selectively inserted into the uterine arteries and the uterine fibroids are sclerosed and embolized with special embolic materials, so that the blood supply of the fibroids is interrupted and they lose nutrition and “starve to death”. The fibroids are then “starved” due to loss of nutrients, followed by degeneration, necrosis, fibrosis and shrinkage. The characteristics of interventional treatment are: minimally invasive, no incision required, and quick recovery. Intraoperative intermittent embolization with ultra-low pressure can prevent embolic agent reflux misembolization and avoid complications. The indications for interventional treatment are symptomatic uterine fibroids of 5 cm or more. A large number of domestic case studies have reported that uterine artery embolization has little effect on sex hormones and ovarian secretory function and allows normal conception and delivery.